newsfilter
← Latest News
GlobeNewswire·

Acasti Announces First Quarter 2024 Financial Results and Business Highlights

New leadership team singularly focused on executing GTX-104 strategyAnnounced alignment with the U.S. Food and Drug Administration (FDA) for Pivotal STRIVE-ON Phase 3 Safety Trial for GTX-104 with first patient expected